Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Steroids. 2011 Feb 1;76(9):921–928. doi: 10.1016/j.steroids.2011.01.008

Fig. 2.

Fig. 2

Western blot analyses of PR-positive and PR-negative breast cancer cell lines using two C-terminal PR antibodies. M: prestained (left) and Western (right) protein size marker; T47D: T47D Yb cell lysate; 231: MDA-MB-231 cell lysate; 231-mPRα: mPRα transfected MDA-MB-231 cell lysate; 468: MDA-MB-468 cell lysate. Sample proteins: 40μg/lane. Left panel, detected with 2C11F11 anti PR C-terminus antibody from Santa Cruz. Right panel, detected with C-19 antibody from same source.